Bicycle Therapeutics plc
BCYC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$169,031 | -$180,664 | -$112,717 | -$66,819 |
| Dep. & Amort. | $7,174 | $6,546 | $3,689 | $1,409 |
| Deferred Tax | -$5,226 | $3,306 | -$4,976 | -$1,668 |
| Stock-Based Comp. | $38,081 | $32,477 | $26,779 | $12,083 |
| Change in WC | -$33,461 | $76,663 | $672 | $38,065 |
| Other Non-Cash | -$2,261 | $1,044 | $442 | $2,136 |
| Operating Cash Flow | -$164,724 | -$60,628 | -$86,111 | -$14,794 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,235 | -$2,929 | -$18,987 | -$2,030 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,235 | -$2,929 | -$18,987 | -$2,030 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$31,905 | $0 | $0 | $15,000 |
| Stock Issued | $544,127 | $249,345 | $5,703 | $298,542 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7,528 | $682 | $989 | $7,183 |
| Financing Cash Flow | $519,750 | $250,027 | $6,692 | $320,725 |
| Forex Effect | -$694 | $1,346 | -$1,120 | -$1,211 |
| Net Chg. in Cash | $353,097 | $187,816 | -$99,526 | $302,690 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $526,970 | $339,154 | $438,680 | $135,990 |
| End Cash | $880,067 | $526,970 | $339,154 | $438,680 |
| Free Cash Flow | -$165,959 | -$63,557 | -$105,098 | -$16,824 |